TYLER ROSHAK: Open Payments
NPI 1952091480 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,721 in 118 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,189 · 2025 $3,721
Food & beverage: $3,375Education: $346
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $762 |
| GENZYME CORPORATION | 14 | $481 |
| Janssen Biotech, Inc. | 12 | $462 |
| Novartis Pharmaceuticals Corporation | 14 | $389 |
| E.R. Squibb & Sons, L.L.C. | 8 | $302 |
| Galderma Laboratories, L.P. | 6 | $285 |
| UCB, Inc. | 3 | $280 |
| PFIZER INC. | 13 | $241 |
| Organon LLC | 1 | $125 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $122 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Sotyktu, Bimzelx, NEMLUVIO, COSENTYX.
Industry payments across KY — which companies pay providers there.
